Kansas Prescription Drug & Opioid Advisory Committee
The Kansas Prescription Drug and Opioid Advisory Committee aims to increase education and awareness and prevent substance use and misuse disorders while connecting individuals who use drugs with treatment and wraparound services. The multidisciplinary stakeholder group is composed of state and local government, health systems, professional associations, community-based programs, academic institutions, public safety and first responders.
The committee is facilitated by DCCCA, Inc., and supported by the Kansas Department for Aging and Disability Services (KDADS) and the Kansas Department of Health and Environment (KDHE).
Priority Areas of Need
The committee identified five priority areas of need, with an additional need for data and monitoring intertwined within each area.
- Implement coordinated statewide health communication campaigns
- Promote safe use, storage, and disposal of prescription drugs
- Develop and disseminate educational materials for professional and non-professional audiences
- Increase the number of community coalitions addressing prescription drug and illicit opioid misuse/overdose
- Collect, analyze, use, and disseminate surveillance data to inform prevention efforts and monitor trends
View the Prevention Appendix (PDF). Prevention Subcommittee meeting minutes are available here.
- Provide educational opportunities on evidence-based practices for opioid use disorder (OUD), medication assisted treatment (MAT), and pain management
- Develop a joint committee to engage subject matter experts to identify and promote best practices
- Increase registration and use of Kansas's prescription drug monitoring program, K-TRACS
- Develop and disseminate a comprehensive resource toolkit for prescribers
- Develop and implement opioid prescribing policies and prior authorizations
- Increase access and utilization of SBIRT
View the Provider Education Appendix (PDF). Provider Subcommittee meeting minutes are available here.
Treatment & Recovery
- Expand access and utilization of MAT for OUD
- Expand peer support services, to support a comprehensive treatment and recovery-oriented system of care
- Increase access to sober living programs in Kansas accepting MAT/OUD patients
- Increase access to residential and medically managed withdrawal treatment services for OUD
- Recommend Kansas implement workforce development programs to increase appeal of the addiction profession
View the Treatment and Recovery Appendix (PDF). Treatment and Recovery Subcommittee meeting minutes are available here.
- Increase utilization of evidence-based OUD treatment and recovery services among justice-involved populations
- Increase awareness, availability, and utilization of Naloxone within Kansas law enforcement agencies
- Provide face to face and online training opportunities to current and prospective law enforcement officers
- Recommend that Kansas enact a 911 Good Samaritan Law
View the Law Enforcement Appendix (PDF). Law Enforcement Subcommittee meeting minutes are available here.
Neonatal Abstinence Syndrome (NAS)
- Promote prevention activities for OUD prior to pregnancy
- Promote standardized universal screenings to identify those at risk
- Increase access of substance use treatment for pregnant women with OUD
- Identify standardized best practices for diagnosis, coding, and tracking of NAS
- Establish a reporting protocol for tracking NAS cases
- Facilitate connection/access to services for mom and baby
- Provide NAS training opportunities for healthcare professionals through the Vermont Oxford Network
View the Neonatal Abstinence Syndrome Appendix (PDF). NAS Subcommittee meeting minutes are available here.